United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 16, 2026 · Filed Oct 19, 2026

On Oct 16, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$534.66 for US$5.08M under a trading plan, leaving 324,443 shares. Filed Oct 19, 2026 (Form 4).

Sold
9,500 shares
Price
US$534.66 average (US$530.48 to US$543.85)
Value
US$5.08M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 16, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 16, 2026Common StockSale240US$530.48333,703Indirect
Oct 16, 2026Common StockSale1,024US$531.54332,679Indirect
Oct 16, 2026Common StockSale2,378US$532.46330,301Indirect
Oct 16, 2026Common StockSale1,818US$533.32328,483Indirect
Oct 16, 2026Common StockSale640US$534.41327,843Indirect
Oct 16, 2026Common StockSale535US$535.67327,308Indirect
Oct 16, 2026Common StockSale865US$536.66326,443Indirect
Oct 16, 2026Common StockSale760US$537.74325,683Indirect
Oct 16, 2026Common StockSale401US$538.55325,282Indirect
Oct 16, 2026Common StockSale239US$539.60325,043Indirect
Oct 16, 2026Common StockSale169US$541.62324,874Indirect
Oct 16, 2026Common StockSale391US$542.67324,483Indirect
Oct 16, 2026Common StockSale40US$543.85324,443Indirect

Source

Download original · View original at SEC

Related